Screener
Merck & Co. MRK Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Net margin | 4.8%-21.0pp | 13.6%-13.7pp | 28.1%+1.4pp | 29.6%— | 25.8%— | |
| Valuation | ||||||
| Market capitalization | $321.57B+60.4% | $297.4B+31.2% | $261.26B+3.8% | $209.64B-27.1% | $201.69B-35.7% | |
| Price / earnings | 101.4×+89.2× | 33.3×+20.3× | 14.3×-0.4× | 11×— | 12.3×— | |
| Price / sales | 4.8×+1.7× | 4.5×+1.0× | 4×+0.1× | 3.3×-1.3× | 3.2×-1.8× |
FAQ
- Where do Merck & Co.'s ratios come from?
- Every ratio is computed from Merck & Co.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
